Get the Stockscreener App
15.36
0.19%
-0.03
After Hours:
15.36
Caredx Inc stock is traded at $15.36, with a volume of 1.68M.
It is down -0.19% in the last 24 hours and down -19.37% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$15.39
Open:
$15.52
24h Volume:
1.68M
Relative Volume:
1.84
Market Cap:
$835.21M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-5.71
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
+2.40%
1M Performance:
-19.37%
6M Performance:
-35.05%
1Y Performance:
+38.88%
1-Day Range:
$15.21
$16.22
1-Week Range:
$14.09
$16.22
52-Week Range:
$12.53
$34.84
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
15.36 | 835.21M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDX, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
CareDx Director Makes a Significant Stock Sale! - TipRanks
Insider Sell: Christine Cournoyer Sells 16,700 Shares of CareDx Inc (CDNA) - GuruFocus
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance
CareDx (CDNA) Maintains Overweight Rating and $40 Price Target | CDNA Stock News - GuruFocus
Analyst Expectations For CareDx's Future - Benzinga
CareDx (CDNA) Stock Rating and Price Target Update | CDNA Stock News - GuruFocus
CareDx outlines $365M-$375M 2025 revenue target while advancing transplant solutions - MSN
CDNA 7/22/22 DEADLINE: Lieff Cabraser Urges CareDx Investors to Contact Us About Pending Securities Fraud Action - ACCESS Newswire
Insider Sell: Peter Maag Sells 13,281 Shares of CareDx Inc (CDNA) - GuruFocus
Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 28% Undervaluation? - simplywall.st
BTIG cuts CareDx stock price target to $30, maintains Buy rating - Investing.com Australia
CareDx, Inc (NASDAQ:CDNA) Q1 2025 Earnings Call Transcript - Insider Monkey
An Intrinsic Calculation For CareDx, Inc (NASDAQ:CDNA) Suggests It's 28% Undervalued - Yahoo Finance
CareDx First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
CareDx (CDNA) Stock Sees Target Price Cut by BTIG Amid Market Vo - GuruFocus
CareDx Inc. Reports Strong Growth Amid Challenges - TipRanks
BTIG cuts CareDx stock price target to $30, maintains Buy rating By Investing.com - Investing.com South Africa
CareDx price target lowered to $30 from $35 at BTIG - TipRanks
CareDx (CDNA) Reports Strong Q1 2025 Earnings Growth - GuruFocus
CareDx: Q1 Earnings Snapshot - New Haven Register
CareDx Inc (CDNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments - Yahoo Finance
CareDx Reports First Quarter 2025 Results | CDNA Stock News - GuruFocus
CareDx Q1 2025 slides: revenue up 18%, seventh consecutive quarter of volume growth By Investing.com - Investing.com South Africa
CareDx Reports Strong Q1 2025 Growth - TipRanks
CareDx Inc (CDNA) Q1 2025 Earnings: EPS Beats Estimates with Rev - GuruFocus
Earnings call transcript: CareDx beats Q1 2025 EPS expectations By Investing.com - Investing.com Canada
Caredx Inc earnings beat by $0.28, revenue topped estimates - Investing.com India
Earnings call transcript: CareDx beats Q1 2025 EPS expectations - Investing.com
CareDx (CDNA) Tops Q1 Earnings Estimates - Yahoo Finance
CareDx Q1 2025 slides: revenue up 18%, seventh consecutive quarter of volume growth - Investing.com India
CareDx (CDNA) Forecasts Strong Financial Performance for FY25 | - GuruFocus
CareDx (CDNA) Reports Strong Q1 Revenue with Growth in Kidney Su - GuruFocus
CareDx Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CareDx, Inc. SEC 10-Q Report - TradingView
Earnings Flash (CDNA) CAREDX INC. Reports Q1 Adjusted EPS $0.09 - marketscreener.com
Earnings Flash (CDNA) CAREDX INC. Reports Q1 Revenue $84.7M, vs. FactSet Est of $84.4M - marketscreener.com
CareDx Reports First Quarter 2025 Results - The Joplin Globe
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Repligen (RGEN) and CareDx (CDNA) - The Globe and Mail
CareDx Announces New Data on AlloSure Lung Presented at 2025 Int - GuruFocus
CareDx (CDNA) Presents New Data on AlloSure Lung at Key Transpla - GuruFocus
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting - BioSpace
CareDx Inc (CDNA) Trading Down 3.14% on Apr 28 - GuruFocus
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Novack Jeffrey Adam | Secretary and General Counsel |
May 05 '25 |
Sale |
14.70 |
2,688 |
39,514 |
121,350 |
0.60%
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):